InvestSMART

CSL Limited (ASX: CSL) - Announcements

Current share price for CSL : $173.180 1.32 (0.76%)+

ASX company news and announcements for CSL Limited (CSL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All CSL Limited (CSL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than CSL Limited (CSL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for CSL Limited (CSL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$83,082 Update - Dividend/Distribution - CSL 13 Mar 2026 8:28AM $141.040 $173.180 risen by 22.79%
$83,082 Update - Notification of buy-back - CSL 13 Mar 2026 8:28AM $141.040 $173.180 risen by 22.79%
$83,082 Update - Notification of buy-back - CSL 12 Mar 2026 8:29AM $142.580 $173.180 risen by 21.46%
$83,082 Update - Notification of buy-back - CSL 11 Mar 2026 8:30AM $144.560 $173.180 risen by 19.80%
$83,082 Update - Notification of buy-back - CSL 6 Mar 2026 8:25AM $146.490 $173.180 risen by 18.22%
$83,082 Update - Notification of buy-back - CSL 5 Mar 2026 8:24AM $142.860 $173.180 risen by 21.22%
$83,082 Notification regarding unquoted securities - CSL 4 Mar 2026 4:36PM $142.860 $173.180 risen by 21.22%
$83,082 Update - Notification of buy-back - CSL 4 Mar 2026 8:23AM $145.240 $173.180 risen by 19.24%
$83,082 Update - Notification of buy-back - CSL 3 Mar 2026 8:20AM $147.300 $173.180 risen by 17.57%
$83,082 Update - Notification of buy-back - CSL 2 Mar 2026 8:24AM $146.760 $173.180 risen by 18%
$83,082 Update - Notification of buy-back - CSL 27 Feb 2026 8:09AM $146.020 $173.180 risen by 18.60%
$83,082 Update - Notification of buy-back - CSL 26 Feb 2026 8:11AM $145.110 $173.180 risen by 19.34%
$83,082 Update - Notification of buy-back - CSL 25 Feb 2026 8:13AM $145.000 $173.180 risen by 19.43%
$83,082 Update - Notification of buy-back - CSL 24 Feb 2026 8:14AM $147.380 $173.180 risen by 17.51%
$83,082 Appendix 3Y - Costa Saroukos 23 Feb 2026 4:19PM $147.380 $173.180 risen by 17.51%
$83,082 Appendix 3Y - Cameron Price 23 Feb 2026 4:18PM $147.380 $173.180 risen by 17.51%
$83,082 Update - Notification of buy-back - CSL 23 Feb 2026 8:29AM $153.270 $173.180 risen by 12.99%
$83,082 Notification regarding unquoted securities - CSL 20 Feb 2026 4:36PM $153.270 $173.180 risen by 12.99%
$83,082 Update - Notification of buy-back - CSL 20 Feb 2026 8:24AM $154.190 $173.180 risen by 12.32%
$83,082 Change of Director's Interest Notice 19 Feb 2026 2:43PM $153.890 $173.180 risen by 12.53%
$83,082 Update - Notification of buy-back - CSL 19 Feb 2026 8:11AM $152.740 $173.180 risen by 13.38%
$83,082 Notification regarding unquoted securities - CSL 18 Feb 2026 4:21PM $152.740 $173.180 risen by 13.38%
$83,082 Update - Notification of buy-back - CSL 18 Feb 2026 8:16AM $151.560 $173.180 risen by 14.26%
$83,082 CSL and Lilly enter Licensing Agreement for clazakizumab 18 Feb 2026 8:13AM $151.560 $173.180 risen by 14.26%
$83,082 Update - Notification of buy-back - CSL 17 Feb 2026 8:10AM $152.170 $173.180 risen by 13.81%

76 - 100 of 1177 results

Page 4 of 48

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.